CILIATECH
The purpose of the ciliatech is the research, development, production, exploitation, acquisition and distribution of pharmaceutical and diagnostic products and technologies. The Company may acquire, hold and dispose of any intellectual property rights or licenses of any kind. The Company may enter into any commercial, contractual or financial dealings that are likely to promote the Company's purpose or that are directly or indirectly related to it. It may also set up branch offices in Germany and abroad and participate in or partner with other companies.
CILIATECH
Industry:
Biotechnology Health Diagnostics Pharmaceutical
Founded:
2011-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.ciliatech.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apache GoDaddy DNS GoDaddy GoDaddy Email Starfield Technologies
Official Site Inspections
http://www.ciliatech.com
- Host name: redirect.ovh.net
- IP address: 213.186.33.5
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Ciliatech" on Search Engine
CILIATECH - Glaucoma Innovators | LinkedIn
CILIATECH is a medtech company specialized in ophthalmology, developing a new class of implant to address the increasing need to treat glaucoma durably and with almost zero …See details»
Ciliatech - Crunchbase Company Profile & Funding
Ciliatech is a medtech company specialized in ophthalmology, develops a new class of implant to address the increasing need to treat glaucoma durably and with very minimal …See details»
New glaucoma treatment development: the cilioscleral technique
New glaucoma treatment development: the cilioscleral technique. At the World Glaucoma Congress (WGC) in Rome, Italy this summer, Ciliatech presented preliminary results of …See details»
Ciliatech presents data on first-generation implant at World …
Ciliatech described CID as a groundbreaking device disrupting traditional approaches in glaucoma surgery. It is the first implant that enables surgeons to prolong reduced IOP …See details»
Ciliatech raises $3.87M in series A funding to develop new
Ciliatech SAS secured $3.87 million in series A funding to continue developing its second-generation implant to treat open-angle glaucoma. This round was led by its historical …See details»
Ciliatech Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Ciliatech. Use the PitchBook Platform to explore the full profile.See details»
Ciliatech releases new design of Cilioscleral Interpositioning …
Ciliatech, an ophthalmology medtech company developing a new implant to treat glaucoma durably, has released a new design of its CID (Cilioscleral Interpositioning Device), …See details»
Ciliatech presents groundbreaking concept in glaucoma implants, …
Ciliatech presents groundbreaking concept in glaucoma implants, first to bypass opening anterior eye chamber. Interim results of 12-month follow-up study on new implant that …See details»
Ciliatech Releases New Design for Glaucoma Surgical Device
Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, released a new design of its CID (Cilioscleral Interpositioning …See details»
Ciliatech Presents New Concept in Glaucoma Implants, First
Ciliatech, which is developing a new class of implant to treat glaucoma durably named CID (Cilio-scleral Inter-positioning Device), announced that the interim results of a 12-month …See details»
Ciliatech presents groundbreaking concept in glaucoma implants …
Ciliatech, a medtech company specialized in ophthalmology, is developing a new class of implant to address the increasing need to treat glaucoma durably and with zero adverse …See details»
Ciliatech presents groundbreaking concept in glaucoma implants, …
Ciliatech, a medtech company specialized in ophthalmology, is developing a new class of implant to address the increasing need to treat glaucoma durably and with zero adverse …See details»
Ciliatech Presents 2-Year Postoperative Results on New Cilio …
Ciliatech will present results showing stable IOP over time, within a safe zone average of 15 mmHg, among its second cohort of patients with primary open-angle glaucoma (POAG) …See details»
Ciliatech Releases New Design of Glaucoma Surgical Device CID
CID is the unique glaucoma surgical device used in the cilioscleral technique to lower IOP while preserving the anterior chamber of the eye, which in turn avoids serious medical …See details»
Scientific Resources - Ciliatech
Ciliatech releases new design of glaucoma surgical device CID, following patent reinforcement. Second-generation CID (Cilioscleral Interpositioning Device) makes …See details»
Ciliatech | VentureRadar
Ciliatech is a medtech company specialized in ophthalmology that is developing a new class of implant to address the need to treat glaucoma durably and with zero adverse …See details»
Ciliatech - Funding, Financials, Valuation & Investors - Crunchbase
Ciliatech is a medtech company specialized in ophthalmology.See details»
Two-year post-operative results on new cilio-scleral surgical …
Ciliatech will present results showing stable intraocular pressure (IOP) over time, within a safe zone average of 15 mmHg, among its second cohort of patients with Primary Open …See details»
Ciliatech - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Ciliatech is a medtech company specialized in ophthalmology.See details»